切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2024, Vol. 13 ›› Issue (01) : 26 -31. doi: 10.3877/cma.j.issn.2095-3224.2024.01.005

专家论坛

家族性腺瘤性息肉病患者结直肠息肉的内镜下诊断治疗进展
刘宝帅1, 高显华2,(), 潘受禹1, 曹强坚1, 刘连杰1, 张卫2   
  1. 1. 200433 海军军医大学第一附属医院(上海长海医院)肛肠外科
    2. 200433 海军军医大学第一附属医院(上海长海医院)肛肠外科;200433 上海长海医院遗传性结直肠癌筛查防治中心和遗传性肿瘤家庭阻断中心
  • 收稿日期:2023-10-16 出版日期:2024-02-25
  • 通信作者: 高显华
  • 基金资助:
    国家自然科学基金面上项目(No.82372903); 国家重点研发计划项目(No.2022YFC2503701); 上海市卫生健康委员会卫生行业临床研究专项(No.202240350); 海军军医大学"深蓝"工程"远航"人才计划基金、长海医院"234学科攀峰计划"(No.2020YXK022)

Progress in endoscopic treatment of colorectal polyps in patients with familial adenomatous polyposis

Baoshuai Liu1, Xianhua Gao2,(), Shouyu Pan1, Qiangjian Cao1, Lianjie Liu1, Wei Zhang2   

  1. 1. Department of Colorectal Surgery, the First Affiliated Hospital, Naval Medical University (Shanghai Changhai Hospital), Shanghai 200433, China
    2. Department of Colorectal Surgery, the First Affiliated Hospital, Naval Medical University (Shanghai Changhai Hospital), Shanghai 200433, China; Hereditary Colorectal Cancer Center and Genetic Block Center of Familial Cancer, Changhai Hospital, Shanghai 200433, China
  • Received:2023-10-16 Published:2024-02-25
  • Corresponding author: Xianhua Gao
引用本文:

刘宝帅, 高显华, 潘受禹, 曹强坚, 刘连杰, 张卫. 家族性腺瘤性息肉病患者结直肠息肉的内镜下诊断治疗进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(01): 26-31.

Baoshuai Liu, Xianhua Gao, Shouyu Pan, Qiangjian Cao, Lianjie Liu, Wei Zhang. Progress in endoscopic treatment of colorectal polyps in patients with familial adenomatous polyposis[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(01): 26-31.

家族性腺瘤性息肉病(FAP)是一种以结直肠内多发性腺瘤性息肉为特征的遗传性综合征。广义上,所有的腺瘤性息肉病都可以称为FAP;狭义上,只有APC基因突变引起的腺瘤性息肉病才是FAP。FAP患者的结直肠内会出现数十枚甚至数千枚腺瘤性息肉,发生结直肠癌的风险非常高。预防性全大肠切除术(TPC)或全结肠切除术(TC)是FAP的标准治疗方案。近年来,内镜下治疗结直肠息肉取得了巨大的进步,不仅可以治愈轻表型FAP,还可用于经典型FAP,推迟手术的时机;FAP患者行TPC/TC术后也需要定期行结肠镜监测,以免残余直肠、回肠储袋和肛管移行区发生癌变。随着内镜检查和治疗方法的不断进步,内镜下息肉切除术治疗FAP的适应证在逐渐扩大,内镜下可切除的息肉数目越来越多;TPC/TC的时机被不断地推迟,可以保留直肠的FAP患者也越来越多。内镜下治疗有利于改善患者的排尿排便和性功能,提高生活质量;但需要反复进行,有出血、穿孔和癌变的风险,而且治疗费用高。其长期结果和成本效益还有待进一步评估。

Familial adenomatous polyposis (FAP) is a hereditary syndrome characterized by multiple adenomatous polyps in the colon and rectum. The broad definition of FAP includes all patients with adenomatous polyposis; the narrow definition of FAP only includes patients with adenomatous polyposis caused by germline APC gene mutations. Patients with FAP will develop dozens or even thousands of colorectal adenomatous polyps, with extremely high risks of colorectal cancer. Prophylactic total proctocolectomy (TPC) or total colectomy (TC) is the standard treatment for FAP. In recent years, endoscopic treatment of colorectal cancer polyps in FAP patients has achieved great progress. It can not only be used to cure attenuated FAP, but also can be used to treat patients with classic FAP to postpone the timing of TPC/TC. In addition, after TPC/TC, FAP patients also require regular endooscopic monitoring and treatment to prevent cancer in the residual rectum, ileal pouch and anal transition zone. With the continuous advancement of endoscopic examination and treatment methods, the indications of endoscopic polypectomy are gradually expanding, and the number and size of polyps that can be treated by endoscopic treatment have been increasing. The timing of TPC/TC has being postponed, and the rectum could be retained in more and more patients with FAP. Endoscopic treatment of FAP will help improve patient’s urinary, defecation and sexual function, and improve their quality of life. However, due to the required repeated procedures, it carries high risks of intestinal bleeding, perforation and canceration, and its treatment cost is also very high. Further studies are required to evaluate its long-term results and cost-effectiveness.

图1 内镜下治疗CFAP患者的结直肠息肉。患者,女,14岁,CFAP患者,有APC基因突变,母亲死于"FAP术后的硬纤维瘤"。因为这位患者年龄较小,如果手术,发生硬纤维瘤的风险很高,与医生交流后,选择了每3个月做一次内镜下治疗。该患者的结肠里面有数百枚息肉,起初每3个月治疗一次,治疗6次之后改为每6个月一次,每次肠镜都要摘除数十枚息肉。目前已经过去6年多,总共做了20次。最后一次是2023-7-24,息肉控制得比较好,息肉数目一直没有减少,但是没有大的息肉,只有直径小于5 mm的息肉(治疗团队:刘连杰教授和高显华教授)
[1]
van Leerdam ME, Roos VH, van Hooft JE, et al. Endoscopic management of polyposis syndromes: European society of gastrointestinal endoscopy (esge) guideline[J]. Endoscopy, 2019, 51(9): 877-895.
[2]
Stone JK, Mehta NA, Singh H, et al. Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome[J]. Fam Cancer, 2023,22(4):413-422.
[3]
Valanzano R, Ficari F, Curia MC, et al. Balance between endoscopic and genetic information in the choice of ileorectal anastomosis for familial adenomatous polyposis[J]. J Surg Oncol, 2007, 95(1): 28-33.
[4]
段光兵,孙会会,王珺文,等.家族性腺瘤性息肉病内镜下诊治研究进展[J].中国实用内科杂志, 2023, 43(7): 589-593.
[5]
Gao XH, Li J, Zhao ZY, et al. Juvenile polyposis syndrome might be misdiagnosed as familial adenomatous polyposis: A case report and literature review[J]. BMC Gastroenterol, 2020, 20(1): 167.
[6]
Aiman S, Chakrapani A, Sawaimoon S, et al. Multiple lymphomatous polyposis: Characteristic endoscopic features[J]. Indian J Gastroenterol, 2015, 34(1): 87.
[7]
NCCN clinical practice guidelines in oncology (nccn guidelines®). Genetic/familial high-risk assessment: Colorectal. Version 1.2023. September 4, 2023. [EB/OL].

URL    
[8]
Tripathi PR, Sen Sarma M, Yachha SK, et al. Gastrointestinal polyps and polyposis in children: Experience of endoscopic and surgical outcomes[J]. Dig Dis, 2021, 39(1): 25-32.
[9]
Ishikawa H, Yamada M, Sato Y, et al. Intensive endoscopic resection for downstaging of polyp burden in patients with familial adenomatous polyposis (j-fapp study iii): A multicenter prospective interventional study[J]. Endoscopy, 2023, 55(4): 344-352.
[10]
Ishikawa H, Mutoh M, Iwama T, et al. Endoscopic management of familial adenomatous polyposis in patients refusing colectomy[J]. Endoscopy, 2016, 48(1): 51-55.
[11]
Murano T, Ikematsu H, Shinmura K, et al. Endoscopic management of familial adenomatous polyposis targeting colorectal lesions greater than 5 mm in size: A single-center retrospective study[J]. Fam Cancer, 2023, 22(1): 83-89.
[12]
van Leerdam ME, Latchford A. Can innovation in endoscopic therapy alter clinical outcomes in patients with familial adenomatous polyposis?[J]. Endosc Int Open, 2021, 9(9): E1445-e1446.
[13]
Hurlstone DP, Saunders BP, Church JM. Endoscopic surveillance of the ileoanal pouch following restorative proctocolectomy for familial adenomatous polyposis[J]. Endoscopy, 2008, 40(5): 437-442.
[14]
Pasquer A, Benech N, Pioche M, et al. Prophylactic colectomy and rectal preservation in fap: Systematic endoscopic follow-up and adenoma destruction changes natural history of polyposis[J]. Endosc Int Open, 2021, 9(7): E1014-1022.
[15]
Anele CC, Xiang J, Martin I, et al. Regular endoscopic surveillance and polypectomy is effective in managing rectal adenoma progression following colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis[J]. Colorectal Dis, 2022, 24(3): 277-283.
[16]
Aelvoet AS, Pellisé M, Bastiaansen BAJ, et al. Personalized endoscopic surveillance and intervention protocols for patients with familial adenomatous polyposis: The european fap consortium strategy[J]. Endosc Int Open, 2023, 11(4): E386-393.
[17]
Mathews AA, Draganov PV, Yang D. Endoscopic management of colorectal polyps: From benign to malignant polyps[J]. World J Gastrointest Endosc, 2021, 13(9): 356-370.
[18]
Sugimoto T, Yoichi T, Suzuki K, et al. Endoscopic submucosal dissection to treat ileal high-grade dysplasia after ileoanal anastomosis for familial adenomatous polyposis: Report of a case[J]. Clin J Gastroenterol, 2014, 7(6): 481-483.
[19]
Sansone S, Nakajima T, Saito Y. Endoscopic submucosal dissection of a large neoplastic lesion at the ileorectal anastomosis in a familial adenomatous polyposis patient[J]. Dig Endosc, 2017, 29(3): 390-391.
[20]
Mann R, Gajendran M, Umapathy C, et al. Endoscopic management of complex colorectal polyps: Current insights and future trends[J]. Front Med (Lausanne), 2022, 8: 728704.
[1] 杨建波, 马欢, 黄小梅, 刘华柱. 结肠镜辅助下EMR、CSP和RFA术治疗直径<1cm结直肠息肉的疗效和安全性比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 76-79.
[2] 袁成雪, 张宗霞, 许婷, 斯郎拉姆. 三种内镜手术治疗结肠息肉的效果及安全性观察[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(01): 78-81.
[3] 吴俊嶺, 孟科, 刘江涛, 孙刚. 基于HVPG分层的门脉高压内镜治疗中远期疗效研究[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(02): 100-105.
[4] 陈健, 周静洁, 夏开建, 王甘红, 刘罗杰, 徐晓丹. 基于卷积神经网络实现结直肠息肉的实时检测与自动NICE分型(附视频)[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(03): 217-228.
[5] 姚瑶, 高扬, 单军奇, 李昕豫, 韩玮, 李增军, 孙燕来. 一个新的APC基因内含子c.531+6T>G变异导致的家族性腺瘤性息肉病病例报告[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(01): 72-77.
[6] 卢斌, 张天琪, 徐烨, 刘方奇. 中国人群经典型家族性腺瘤性息肉病的临床、病理和分子特征[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(01): 38-44.
[7] 丁富贵, 吴泽涛, 董卫国. 家族性腺瘤性息肉病临床特征及生物信息学分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 512-518.
[8] 梁艳娉, 陈燕柔, 梁运啸, 白飞虎, 吴斌, 王省. 华南地区门静脉高压食管胃静脉曲张出血内镜治疗现状调研分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 390-395.
[9] 刘燚隆, 党荣广, 艾蓉, 张凯. 肝硬化合并静脉曲张出血患者内镜治疗后再出血风险的模型建立与验证[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 336-342.
[10] 牟一, 张力凡, 胡兵. 圈套器冷切除术在结直肠息肉应用中的最新进展[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 253-258.
[11] 马梓粼, 张帅, 何占娣, 王娟, 孙国辉, 黄昂, 杨竞, 钟立森, 张晓彬, 刘迎娣, 令狐恩强. 改良的内镜下静脉曲张套扎术治疗肝硬化食管静脉曲张的疗效研究[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 225-232.
[12] 代剑华, 覃语思, 陈磊, 彭志红, 陈瑶, 刘俐, 吴宏博, 许森林, 李川, 钱锋, 彭贵勇. 术前评估超内镜治疗适应证胃癌的超级微创新选择:内镜、腔镜序贯治疗[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 217-224.
[13] 张帅, 张晓彬, 刘迎娣, 令狐恩强. 肝硬化食管胃静脉曲张的内镜管理[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(03): 191-194.
[14] 胡兵. 结直肠息肉冷切[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(01): 72-72.
[15] 郭明杰, 周春起, 余佳慧, 李世红, 朱红梅, 刘雁军, 杨华武. 肥胖与胃食管反流病的关系及减重术后反流治疗研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 184-192.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?